Gut & MicrobiomeClinical TrialPaywall

Synbiotic Supplement Shows Promise for Gut Health and Immunity in Older Adults

University study tests whether combining probiotics with prebiotics can restore healthy gut bacteria and immune function in people over 65.

Saturday, March 28, 2026 0 views
Published in ClinicalTrials.gov
Clinical trial visualization: Synbiotic Supplement Shows Promise for Gut Health and Immunity in Older Adults

Summary

Researchers at the University of Dundee investigated whether a synbiotic supplement could improve gut health and immune function in older adults. As we age, our gut bacteria composition changes dramatically, leading to digestive issues, increased inflammation, and weakened immune responses. The study tested a combination of Bifidobacterium longum bacteria with inulin prebiotic in 49 participants aged 65 and older. Using a crossover design, volunteers received either the synbiotic or placebo for four weeks, followed by a washout period, then switched treatments. This approach allowed researchers to measure changes in gut bacteria composition and immune markers within the same individuals, providing clearer evidence of the supplement's effects.

Detailed Summary

A University of Dundee clinical trial examined whether synbiotic supplementation could reverse age-related decline in gut health and immune function. Aging significantly alters gut bacteria composition, contributing to digestive problems, chronic inflammation, and compromised immunity that affects quality of life in older adults.

The randomized, double-blind, placebo-controlled crossover study enrolled 49 participants aged 65 and older. Each volunteer received both the synbiotic supplement and placebo in different phases, separated by a four-week washout period. The synbiotic combined Bifidobacterium longum bacteria with Synergy 1 inulin prebiotic, a formulation previously shown to reduce inflammation in inflammatory bowel disease patients.

Researchers measured changes in gut bacteria composition and immune system markers throughout the 12-week study period. The crossover design strengthened the study by allowing each participant to serve as their own control, reducing variability from individual differences in baseline gut health and immune function.

This completed trial represents important research into practical interventions for healthy aging. The synbiotic approach targets the root cause of age-related gut dysfunction by simultaneously introducing beneficial bacteria and providing nutrients to support their growth. Previous research with this specific combination showed anti-inflammatory effects, suggesting potential benefits beyond digestive health.

While full results await publication, this study addresses a critical aspect of longevity research. Maintaining gut health and immune function as we age could significantly impact overall healthspan, potentially reducing infection risk, improving nutrient absorption, and supporting the gut-brain axis that influences cognitive health and mood regulation.

Key Findings

  • Study completed testing synbiotic effects on gut bacteria and immunity in adults 65+
  • Crossover design allowed participants to serve as their own controls for stronger evidence
  • Intervention combined Bifidobacterium longum with inulin prebiotic for 4-week periods
  • Research targets age-related gut dysfunction that contributes to inflammation and infection risk

Methodology

Randomized, double-blind, placebo-controlled crossover trial with 49 participants aged 65 and older. Study duration was 12 weeks total with 4-week treatment periods separated by washout phases. Each participant received both synbiotic and placebo treatments in different phases.

Study Limitations

Small sample size of 49 participants may limit generalizability to broader older adult populations. Results and statistical significance are not yet published, making it difficult to assess clinical meaningfulness of any observed effects.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.